Veterinary Medicines

NEO-BACTERINA Suspensión inyectable para bovino, ovino y caprino

Authorised
  • Pasteurella multocida, serotype A, strains P-1062 and 11-A, Inactivated
  • Mannheimia haemolytica, serotype A1, strain 43270 and strain S 10R, Inactivated
  • Mannheimia haemolytica, serotype A1, strains 43270 and S 10R, leucotoxoid
Download as PDF

Product identification

Medicine name:
NEO-BACTERINA Suspensión inyectable para bovino, ovino y caprino
Active substance:
  • Pasteurella multocida, serotype A, strains P-1062 and 11-A, Inactivated
  • Mannheimia haemolytica, serotype A1, strain 43270 and strain S 10R, Inactivated
  • Mannheimia haemolytica, serotype A1, strains 43270 and S 10R, leucotoxoid
Target species:
  • Cattle
  • Sheep
  • Goat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Pasteurella multocida, serotype A, strains P-1062 and 11-A, Inactivated
    20.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A1, strain 43270 and strain S 10R, Inactivated
    16.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Mannheimia haemolytica, serotype A1, strains 43270 and S 10R, leucotoxoid
    40.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Goat
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Syva S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Syva S.A.U.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2835 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."